Insider trades
Andrew Gengos, Director of Turn Therapeutics TTRX, has filed 15 purchases and 3 sales on the open market. The latest trade was on 06/04.
Andrew Gengos
Director
- Company
- Turn Therapeutics TTRX
- First filing
- 23/05/22
- Trades
- 33 trades
- Buys / sales
- 15 / 3
- 12-month net buying
- No record
- Last trade
- 06/04
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/06/27 | 25/06/30 | 10,000 sh2 trades | $3.93avg. | $39,300 | +66.7% | |
| Open-market buy | 25/06/13–25/06/16 | 25/06/16 | 15,000 sh3 trades | $3.81avg. | $57,100 | No record | |
LeonaBioLONA | Open-market sale | 24/09/05 | 24/09/05 | 1,272 sh | $0.57 | $725.04 | −1.3% |
LeonaBioLONA | Open-market saleAmendment | 24/01/05 | 24/02/16 | 1,208 sh | $2.91 | $3,515.28 | −1.4% |
LeonaBioLONA | Open-market sale | 23/01/05 | 24/01/08 | 1,208 sh | $2.91 | $3,515.28 | −1.4% |
LONA | Open-market buy | 23/06/07 | 23/06/09 | 15,000 sh3 trades | $3.43avg. | $51,451.88 | +23.1% |
LONA | Open-market buy | 23/06/02–23/06/05 | 23/06/06 | 65,012 sh7 trades | $2.95avg. | $191,640.62 | No record |
